The effect of anti-neoplastic drugs on murine acquired immunodeficiency syndrome

Science. 1991 Jan 18;251(4991):305-8. doi: 10.1126/science.1987646.

Abstract

The murine acquired immunodeficiency syndrome (MAIDS) is associated with proliferation of target cells that have been infected by a defective retrovirus. To control the growth of this primary neoplasia, virus-inoculated mice were treated with anti-neoplastic drugs. Paradoxically, cyclophosphamide, which is also immunosuppressive, was very effective in preventing the appearance and progression of the disease, in restoring a normal T cell function, and in depleting the number of infected target cells. This result suggests that the proliferating infected target cells were responsible for the immunodeficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Blotting, Northern
  • Blotting, Southern
  • Cell Division
  • Cyclophosphamide / therapeutic use
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred BALB C
  • Murine Acquired Immunodeficiency Syndrome / drug therapy*
  • Murine Acquired Immunodeficiency Syndrome / pathology
  • RNA, Viral / analysis
  • Spleen / pathology
  • Virus Replication

Substances

  • Antineoplastic Agents
  • RNA, Viral
  • Cyclophosphamide